In conclusion, we provide substantial evidence showing that insulin, leptin, and pro-inflammatory cytokines are able to activate the CB and modulate its function and that probably hyperinsulinemia, hyperleptinemia, and high pro-inflammatory cytokine levels are determinant factors contributing to the CB overactivation that contributes to the genesis of metabolic diseases. The gene discussed is INS; the disease is Other metabolic disease.